Pyxis Oncology grabs $152m Series B
Pyxis Oncology, a provider of biologics, has secured $152 million in Series B financing.
Pyxis Oncology, a provider of biologics, has secured $152 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination